Korro Bio, Inc. (NASDAQ:KRRO) Given Consensus Rating of “Buy” by Analysts
Shares of Korro Bio, Inc. (NASDAQ:KRRO – Get Free Report) have been assigned a consensus rating of “Buy” from the seven ...
Korro Bio price target lowered to $95 from $105 at RBC Capital
RBC Capital lowered the firm’s price target on Korro Bio (KRRO) to $95 from $105 and keeps an Outperform rating on the shares. The firm notes ...
Is Korro Bio (NASDAQ:KRRO) In A Good Position To Invest In Growth?
So, the natural question for Korro Bio (NASDAQ:KRRO) shareholders is whether they should be concerned by its rate of cash burn. In this article, we define cash burn as its annual (negative) free cash ...
Korro Reports Full Year 2024 Financial Results and Provides Business Updates
Completed dosing of first two cohorts in Phase 1/2a REWRITE Clinical Study of KRRO-110 for Alpha-1 Antitrypsin Deficiency (AATD); Interim ...
The Manila Times3d
Matador Technologies Inc. to List on OTCQB
Matador Technologies Inc. ('Matador” or the 'Company”) (TSXV: MATA) is pleased to announce that it has received approval to list its common shares on the OTC Markets under the ticker symbol ...